Panelists discuss how to effectively collaborate with payers to ensure access to necessary medications for patients with small cell lung cancer (SCLC), while also exploring best practices for patient ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

The companies focused on a subset of COPD patients with Type 2 inflammation, a type of immune response Dupixent disrupts. They enrolled into a pair of late-stage trials nearly 1,900 people, all of ...

With the label expansion, Dupixent becomes the first biologic treatment for COPD patients in the U.S. The IL-4 and IL-13 inhibitor is approved to be used as an add-on maintenance treatment by ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

The FDA approved dupilumab (Dupixent; Regeneron/Sanofi) today for treating patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. 1 This approval ...

Exclusive A fast-growing London GP practice has admitted to mistakenly registering patients without their consent, after GPs at other local practices raised concerns about losing ‘significant’ numbers ...

A world café approach was used with patients, faculty, and students, followed by small group discussions. Curriculum changes included separate education about transgender health needs and specific ...

The presentation was entitled “Detecting the onset and peak symptoms of exacerbations of COPD by analyzing speech.” “There were clear differences between patients’ recordings on a normal day and on ...